Study of Immunotherapy in Combination With Chemotherapy in HER2-negative Inflammatory Breast Cancer
Condition: Inflammatory Breast Cancer Interventions: Drug: Pembrolizumab Injection; Drug: neoadjuvant (F)EC-paclitaxel chemotherapy Sponsors: Institut Paoli-Calmettes; MSD France Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Breast Cancer | Cancer | Cancer & Oncology | Chemotherapy | France Health | HER2 | Immunotherapy | Inflammatory Breast Cancer | Study